HCV Testing Policy

Print

HBV Testing Policy v1.1 -> v1.2

The Expert Reference Committee met via teleconference from October 2015 to March 2016 to review the National Hepatitis B Testing Policy 2012 v1.1. Each section of the Testing Policy was systematically reviewed during these conversations. The recommended changes were incorporated in the revised National Hepatitis B Testing Policy v1.2

Most of the amendments made were minor wording changes to aid clarification, revisions to include reference to The 2nd National Hepatitis B Strategy 2014-2017 and The Fourth National Aboriginal and Torres Strait Islander Blood Borne Virus & Sexually Transmissible Infections Strategy 2014-2017, and updates to statistical information. Other more significant changes made included:

Section 1.4.2 Mandatory or compulsory testing

  • Testing for HBV is no longer a mandatory condition for performing exposure prone procedures

Section 2.1 Types of hepatitis B diagnostic tests

  • Noted that hepatitis B genotype / mutation conferring resistance is not Medicare rebatable and a fee may be payable
  • Recommending that, when determining protective immunity or its absence in at-risk groups, if anti-HBs is negative should also test for HBsAg and anti-HBc to exclude undiagnosed infection or distant past infection
  • Recommending that, when testing in antenatal women, if possible also perform anti-HBs, to assess the need for vaccination
  • Section amended to state that there are no HBsAg point-of-care (PoC) tests currently approved by the Therapeutic Goods Administration (TGA) for inclusion on the ARTG. If people in the community indicate they have received a positive or negative PoC test  from overseas the result should be confirmed by standard HBV testing in a NATA certified diagnostic laboratory

Section 3.0 Indications for HBV testing

  • Children of women who are HBsAg positive added to the list of contexts where clinical suspicion of HBV infection may occur

Section 3.1.3 All patients undergoing chemotherapy or immunosuppressive therapy

  • Amended to include more detail on the types of situations, risks and intentions behind testing and treatment in this patient group

Section 4.0 Informed consent for testing

  • Clarification added that informed consent must be obtained for HBV testing

Section 5.6.5 Post mortem testing

  • This section has been removed

Section 8.1 Routine testing (antenatal and perinatal testing)

  • Section amended to state that an experienced clinician should assess any woman diagnosed with hepatitis B infection in pregnancy  rather than stating should be referred to a gastroenterologist, hepatologist or Infectious Diseases Unit

 

Updated version:  2015 National HBV Testing Policy v1.2

Previous version:  2012 National HBV Testing Policy v1.1

Print

HCV Testing Policy v1.1 -> v1.2

The previous HCV testing policy was released in 2012 and this version was updated in 2016. Differences in this version 1.2 include:

  • Updated monitoring treatment (see section 2.4)
  • More commentary on testing in Aboriginal and Torres Strait Islander populations and people who inject drugs (see section 3)

Updated version :  2017 National HCV Testing Policy v1.2 (PDF, 1.1MB)

HCV Testing Policy v1.0 -> v1.1

The Expert Reference Committee met via teleconference on 28 May 2013 to review the National Hepatitis C Testing Policy, 2012. Each section of the Testing Policy was systematically reviewed at this meeting. The recommended changes were incorporated in the revised National Hepatitis C Testing Policy, 2012 v1.1.

Most of the amendments made were minor wording changes to aid clarification. Other more significant changes made included:

  • 1.4 Policy Implementation
    • added reference 5 to end of first sentence.
  • 2.0 Diagnostic Strategies
    • a smaller working group was established to rewrite the whole section and incorporate HCV antigen testing. The testing pathway was also reformatted to reflect the inclusion of HCV antigen testing and options if the second immune assay (IA) is negative
  • 3.1.3 Recipients of organs...
    • changed "organs" to "recipients" are screened for HC
  • 3.1.7 Sexual partners of people with HCV
    • changed "The risk of sexual transmission of HCV is low" to "The risk of heterosexual transmission of HCV is low").
  • 3.1.9 Transmission and infection control in healthcare settings
    • dot point 2: changed wording to “Health care workers must not perform EPPs if they are hepatitis C RNA positive (by nucleic acid test)” [as per exact wording in ref 27,  C2.5.1 Responsibilities, Australian Guidelines for the Prevention and Control of Infection in Healthcare (2010)].
    • added dot point 5.
  • 5.1 Conveying a negative result
    • deleted “in the context of conventional testing” from title.
  • 5.2 Conveying a positive result
    • deleted “in the context of conventional testing” from title.
    • changed wording in first and last sentence of first paragraph to clarify a positive result could be a positive Ab or positive HCV RNA result and further testing may be needed if just HCV Ab.
  • 8.1 Routine Testing
    • added “with clinical suspicion of infection (see section 3.0) and/or “ to third sentence.
  • 8.2  Testing of infants born to HCV-infected mothers
    • reworded last paragraph.
  • 11.2 Schedule interpretation
    • changed paragraph wording and department responsible to Dept of Human Services.
    • Changed personal tense in last sentence.

Previous version :  2012 National HCV Testing Policy v1.1 (PDF, 333KB)

Previous version :  2012 National HCV Testing Policy v1.0 (PDF, 439KB)

 

 

Print

ASHM National HIV Testing Policy 2017 

The policy is undergoing an internal review to identify any areas for further updating or addition, given the time delay since the current revision was completed and made available.

The Draft National Testing Policy 2014

The Draft National Testing Policy 2014 was provided to the DoH for endorsement by Commonwealth, States and Territories on 24 March 2014. The Expert Reference Committee thought that the revised draft National Testing Policy should be resubmitted to the BBVSS of the AHPPC for endorsement as it contained two significant changes from the 2011 version, namely:

  • calling for the removal of barriers to self-testing and
  • recommending that test for self-use should be evaluated by the TGA

Both of these recommendations have subsequently been taken up by the Australian Government and the changes were announced by the Minister for Health on 7 July 2014. http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2013-dutton049.htm A copy of the draft policy can be accessed here and the draft appendices here. The document will now be updated to reflect these changes and comments on the draft are welcomed.

HIV Testing Policy v1.2 -> v1.3

Changes were made to

HIV Testing Policy v1.1 -> v1.2

Changes were made to

  • 4.0 Informed consent for testing
    • Emphasise use of appropriate supports when communicating with people
  • 5.0 Conveying HIV test results
    • Emphasise use of appropriate supports when communicating with people
  • 6.0 Surveillance and research
    • Amend duplication of text
  • 8.1 Routine testing
    • Removed redundant sentence
  • 8.2 Testing of infants born to mothers with HIV infection
    • Amend title to Testing of infants born to HIV infected mothers with HIV
      infection
  • 10 HIV testing in prisons
    • Section Added
    • Renumbering of subsequent sections
  • 11 Post-exposure prophylaxis
    • Removed potentially confusing sub-sections 11.1, 11.2, 11.3 and instead referred to National PEP policy
    • Renumbering of subsequent sub-sections
  • 11.1 PEP in health care settings
    • Strengthened obtaining informed consent before testing stored specimens
  • 12.1 Laboratories
    • Added “should” to laboratories submitting testing statistics
  • 13.2  Accreditation
    • Minor changes to make current

Minor changes were made throughout the policy document for consistency and wording.

Click to view HIV Testing Policy version 1.2 changes (PDF 333KB) in detail

The Expert Reference Committee saw these changes as improving the clarity of the document, but not changing its substantive meaning and has notified BBVSS of the AHPPC of these changes.

Updated version : 2011 National HIV Testing Policy v1.2 (PDF, 220kB)

Previous version : 2011 National HIV Testing Policy v1.1 (PDF, 170kB)

HIV Testing Policy v1.0 -> v1.1 

Minor changes were made to:

  • 8.0 Antenatal and perinatal testing
  • 10.3 Follow up testing after post-exposure prophylaxis (PEP)
  • 10.4 PEP in health care settings
  • 12.5 Quality assurance

Click to view HIV Testing Policy version 1.1 changes (PDF, 72kB) in detail.

The Expert Reference Committee saw these changes as improving the clarity of the document, but not changing its substantive meaning and has notified BBVSS of the AHPPC of these changes.

Updated version : 2011 National HIV Testing Policy v1.1 (PDF, 170kB)

Previous version : 2011 National HIV Testing Policy v1.0 (PDF, 183kB)

Download HCV Testing Policy

Download the full
2017 National HCV Testing Policy v1.2 (PDF, 1.1MB)

See what's changed from previous version -->

 

 ASHM_LOGO_

Development of this site and the 2014 and 2017 revisions of the testing policies was supported by: Australian Government Department of Health and Ageing